activities quinolones ciprofloxacin-susceptible ciprofloxacin-resistant methicillin-resistant Staphylococcus aureus vitro activities quinolones fluoroquinolones nalidixic acid acrosoxacin methicillin-resistant Staphylococcus aureus MRSA glycopeptides teicoplanin vancomycin MICs strains ciprofloxacin-susceptible MIC micrograms/ml MRSA strains ciprofloxacin-resistant MIC equal micrograms/ml MRSA following MICs strains micrograms milliliter ciprofloxacin-susceptible -resistant strains tosufloxacin ofloxacin ciprofloxacin pefloxacin acrosoxacin enoxacin fleroxacin norfloxacin nalidixic acid teicoplanin vancomycin mutation rate studies range antibiotic concentrations achievable vivo resistant mutants plates nalidixic acid rate mutation plates low concentrations ciprofloxacin enoxacin rate mutation time-kill studies killing quinolones norfloxacin nalidixic acid Teicoplanin vancomycin bactericidal clinical isolates ciprofloxacin-resistant MRSA different levels patterns quinolone resistance cross-resistance fluoroquinolones complete incomplete cross-resistance nonfluorinated quinolone acrosoxacin 